Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge assists Kesko and Onninen in divestment
Mandate

Vinge assists Kesko and Onninen in divestment

March 20, 2019 M&A

Vinge assists Kesko Oyj and its wholly-owned subsidiary Onninen AB in the divestment of Onninen's HEPAC operations to Solar Sverige AB. 

The divestment is subject to standard closing conditions such as approval by the Swedish Competition Authority. 

Vinge's team consists of counsel Ulrich Ziche and among others associates Filip Brosset, Sebastian Örndahl, Kristoffer Larson, Sara Strandberg, Victor Berg and Hanna Risberg and VDR-specialist Sofie Sundin. 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026